Evaluating COVID-19 Vaccine Willingness and Hesitancy among Parents of Children Aged 5-11 Years with Chronic Conditions in Italy.
COVID-19
Italy
children
chronic condition
hesitancy
parents
vaccination
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
04 Mar 2022
04 Mar 2022
Historique:
received:
31
01
2022
revised:
24
02
2022
accepted:
01
03
2022
entrez:
26
3
2022
pubmed:
27
3
2022
medline:
27
3
2022
Statut:
epublish
Résumé
COVID-19 vaccination has been extended to include children aged 5-11 years. This cross-sectional survey evaluated parental COVID-19 vaccine willingness and hesitancy, and associated factors, for their children aged 5-11 years with chronic conditions. A telephone survey was conducted from 14 December 2021 to 4 January 2022. The questionnaire assessed participants' socio-demographic and health-related information, attitudes towards COVID-19 infection, hesitancy, by using the PACV-5 (Parent Attitudes About Childhood Vaccines Survey Tool), and sources of information. A total of 430 answers were collected anonymously. Respondents with no cohabitant who had been infected by SARS-CoV-2 and having been vaccinated against COVID-19 had a higher concern about the severity of COVID-19. The parents' perceived risk that the child could be infected by SARS-CoV-2 was higher in those more concerned about the severity of COVID-19, with an older child, and who had at least one cohabitant positive for COVID-19. Only 38.8% parents were willing to vaccinate their children against COVID-19. Parents who did not need additional information, those with higher education, those who have been vaccinated against COVID-19, those whose child was older, who had received information on this vaccination from physicians, with higher self-reported concern about the severity of COVID-19, and who had a higher perceived risk that their child could be infected by SARS-CoV-2, expressed a greater willingness to vaccinate their child. Overall, 26.3% were high-hesitant, with a PACV-5 score ≥ 7. Respondents who did not get the COVID-19 vaccine, were less educated, with a lower concern about severity of COVID-19, and with a lower perceived risk that their child could be infected by SARS-CoV-2, were more likely to be high-hesitant. New policies and educational programs regarding COVID-19 vaccination for children with chronic conditions are needed to reduce hesitancy and increase vaccination uptake.
Identifiants
pubmed: 35335028
pii: vaccines10030396
doi: 10.3390/vaccines10030396
pmc: PMC8953590
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Regione Campania
ID : Executive decree n.75/2017 Strategic and nationally relevance objectives indicated in the National Health Plan. FSN 2014, 2015, 2016
Références
Vaccine. 2022 Jan 21;40(2):213-222
pubmed: 34895784
Vaccines (Basel). 2021 Jan 19;9(1):
pubmed: 33477779
Front Public Health. 2021 Nov 05;9:779720
pubmed: 34805084
Expert Rev Vaccines. 2022 Apr;21(4):541-547
pubmed: 34949136
Hum Vaccin Immunother. 2021 Nov 2;17(11):3969-3974
pubmed: 34344258
Vaccine. 2021 Jun 16;39(27):3602-3607
pubmed: 34034950
Vaccine. 2016 Sep 22;34(41):4964-4968
pubmed: 27566902
Hum Vaccin Immunother. 2021 Dec 2;17(12):5076-5081
pubmed: 34715004
Lancet Oncol. 2021 Oct;22(10):1416-1426
pubmed: 34454651
Vaccine. 2021 Dec 20;39(52):7669-7676
pubmed: 34688500
J Affect Disord. 2022 Feb 15;299:196-204
pubmed: 34875283
Vaccine. 2022 Jan 24;40(3):494-502
pubmed: 34906392
PLoS One. 2021 Dec 17;16(12):e0261121
pubmed: 34919580
Hum Vaccin Immunother. 2021 Dec 2;17(12):4993-4998
pubmed: 34623937
Front Public Health. 2021 Oct 27;9:725980
pubmed: 34778168
Clin Ther. 2022 Jan;44(1):e1-e10
pubmed: 34865871
Eur J Pediatr. 2021 Nov;180(11):3405-3410
pubmed: 33999257
Hum Vaccin Immunother. 2020 Nov 1;16(11):2744-2751
pubmed: 32298210
BMC Public Health. 2021 Sep 26;21(1):1759
pubmed: 34565351
Vaccine. 2021 Dec 3;39(49):7140-7145
pubmed: 34763947
Vaccines (Basel). 2021 Sep 02;9(9):
pubmed: 34579219
Pediatrics. 2021 Oct;148(4):
pubmed: 34344800
Vaccines (Basel). 2022 Jan 19;10(2):
pubmed: 35214605
Pediatrics. 2021 Dec 22;:
pubmed: 34935038
Vaccine. 2021 Jul 30;39(33):4716-4722
pubmed: 34119349
Expert Rev Vaccines. 2022 Mar;21(3):385-395
pubmed: 34974779
Front Public Health. 2020 Jul 14;8:381
pubmed: 32760691
Vaccine. 2022 Jan 3;40(1):151-161
pubmed: 34863621
Front Immunol. 2021 Nov 29;12:781161
pubmed: 34912346
Vaccines (Basel). 2021 Apr 10;9(4):
pubmed: 33920109
J Med Internet Res. 2021 Jan 20;23(1):e17187
pubmed: 33470931
JMIR Public Health Surveill. 2021 Nov 9;7(11):e31707
pubmed: 34653014
Vaccines (Basel). 2021 Jun 10;9(6):
pubmed: 34200656
Hum Vaccin Immunother. 2021 Oct 3;17(10):3322-3332
pubmed: 34137670
Vaccine. 2022 Jan 3;40(1):43-51
pubmed: 34857421
Vaccines (Basel). 2021 Sep 30;9(10):
pubmed: 34696223
Expert Rev Vaccines. 2021 Jul;20(7):881-889
pubmed: 33900148
Vaccines (Basel). 2021 Oct 04;9(10):
pubmed: 34696242
J Infect Public Health. 2021 Oct;14(10):1489-1496
pubmed: 34417135
Vaccines (Basel). 2021 Jan 14;9(1):
pubmed: 33466675
Hum Vaccin Immunother. 2020 May 3;16(5):1070-1077
pubmed: 32017643
Eur J Epidemiol. 2021 Feb;36(2):197-211
pubmed: 33649879
Front Public Health. 2021 Jul 26;9:614499
pubmed: 34381748
Int J Environ Res Public Health. 2019 Jun 12;16(12):
pubmed: 31212739
Int J Environ Res Public Health. 2020 Jul 27;17(15):
pubmed: 32727024
Vaccines (Basel). 2021 Mar 18;9(3):
pubmed: 33803730
Vaccines (Basel). 2021 Nov 24;9(12):
pubmed: 34960137
Vaccines (Basel). 2020 Sep 25;8(4):
pubmed: 32992864
Front Immunol. 2021 Jun 14;12:558270
pubmed: 34194418
Vaccines (Basel). 2021 Nov 03;9(11):
pubmed: 34835207
J Infect Public Health. 2021 Oct;14(10):1497-1504
pubmed: 34481723
Hum Vaccin Immunother. 2022 Dec 31;18(1):1-9
pubmed: 34752716